Mezzion Pharma Co.,Ltd. (140410.KQ)
KRW 32600.0
(-5.37%)
KRW 32600.0
(-5.37%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 31.72 Billion | 30.72 Billion | 26.65 Billion | 28.63 Billion | 17.92 Billion |
| Cost of Revenue | 27.83 Billion | 31.03 Billion | 22.95 Billion | 21.19 Billion | 15.01 Billion |
| Gross Profit | 3.88 Billion | -313.44 Million | 3.69 Billion | 7.43 Billion | 2.9 Billion |
| Operating Expenses | 18.37 Billion | 23.01 Billion | 20.49 Billion | 14.96 Billion | 25.71 Billion |
| Selling, General and Administrative Expenses | 9.37 Billion | 10.87 Billion | 10.22 Billion | 7.78 Billion | 14.21 Billion |
| Research and Development Expenses | 938.96 Million | 2.21 Billion | 1.95 Billion | 937.55 Million | 12.14 Billion |
| Other Expenses | 8.06 Billion | -1.39 Billion | 234.16 Million | -2.84 Billion | - |
| Cost and Expenses | 46.2 Billion | 54.05 Billion | 43.45 Billion | 36.16 Billion | 40.73 Billion |
| Operating Income | -14.48 Billion | -23.33 Billion | -16.79 Billion | -7.53 Billion | -24.48 Billion |
| Interest Expense | 164.8 Million | 423.44 Million | 323.41 Million | 320.2 Million | 530.00 |
| Income Tax Expense | 248.07 Million | 388.23 Million | 577.06 Million | 1.03 Billion | 1.02 Billion |
| Earnings before Tax | -12.48 Billion | -35.9 Billion | -13.02 Billion | -12.83 Billion | -22.27 Billion |
| Net Income | -12.72 Billion | -36.29 Billion | -13.6 Billion | -13.82 Billion | -23.3 Billion |
| Earnings Per Share Basic | -451.00 | -1358.00 | -509.70 | -531.67 | -897.09 |
| Earnings Per Share Diluted | -451.00 | -1358.00 | -509.70 | -531.67 | -897.09 |
| Weighted Average Shares Outstanding | 28.22 Million | 26.72 Million | 26.68 Million | 26.01 Million | 25.97 Million |
| Weighted Average Shares Outstanding (Diluted) | 28.22 Million | 26.72 Million | 26.68 Million | 26.01 Million | 25.97 Million |
| Gross Margin | 0.12 | -0.01 | 0.14 | 0.26 | 0.16 |
| EBIT Margin | -0.41 | -0.62 | -0.41 | -0.39 | -1.29 |
| Profit Margin | -0.40 | -1.18 | -0.51 | -0.48 | -1.30 |
| EBITDA | -12.94 Billion | -19.13 Billion | -15.21 Billion | -6.09 Billion | -23.15 Billion |
| Earnings Before Tax Margin | -0.46 | -0.76 | -0.63 | -0.26 | -1.37 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 2.26 Billion | 2.15 Billion | 31.72 Billion | 7.38 Billion | 8.43 Billion | 8.11 Billion |
| Cost of Revenue | 1.78 Billion | 1.67 Billion | 27.83 Billion | 6.38 Billion | 7.18 Billion | 7.17 Billion |
| Gross Profit | 486.6 Million | 486.89 Million | 3.88 Billion | 1 Billion | 1.24 Billion | 940.13 Million |
| Operating Expenses | 5.08 Billion | 4.55 Billion | 18.37 Billion | 4.26 Billion | 4.53 Billion | 4.28 Billion |
| Selling, General and Administrative Expenses | 1.99 Billion | 4.5 Billion | - | 1.66 Billion | 2.56 Billion | 2.33 Billion |
| Research and Development Expenses | 1.58 Billion | - | - | 331 Million | 237.64 Million | 42.29 Million |
| Other Expenses | 435 Thousand | 178.63 Million | -248.55 Million | 9.73 Million | -195.97 Million | -23.69 Million |
| Cost and Expenses | 6.86 Billion | 6.22 Billion | 46.2 Billion | 10.65 Billion | 11.71 Billion | 11.45 Billion |
| Operating Income | -4.59 Billion | -4.06 Billion | -14.48 Billion | -3.26 Billion | -3.28 Billion | -3.34 Billion |
| Interest Expense | 74.48 Million | 79.25 Million | 315.46 Million | 124.53 Million | 59.98 Million | 58.82 Million |
| Income Tax Expense | 134.17 Million | 128.82 Million | 248.07 Million | 331.74 Million | -179.29 Million | 105.5 Million |
| Earnings before Tax | -1.48 Billion | 201.41 Million | -12.48 Billion | -6.01 Billion | -1.15 Billion | -2.8 Billion |
| Net Income | -1.61 Billion | 72.59 Million | -12.72 Billion | -6.34 Billion | -977.88 Million | -2.9 Billion |
| Earnings Per Share Basic | -55.00 | 2.00 | - | -213.49 | -33.12 | -107.38 |
| Earnings Per Share Diluted | -55.00 | 2.00 | - | -212.99 | -33.12 | -107.38 |
| Weighted Average Shares Outstanding | 29.41 Million | 36.29 Million | 28.22 Million | 29.72 Million | 29.52 Million | 27.07 Million |
| Weighted Average Shares Outstanding (Diluted) | 29.41 Million | 30.59 Million | 28.22 Million | 29.78 Million | 29.52 Million | 27.07 Million |
| Gross Margin | 0.21 | 0.23 | 0.12 | 0.14 | 0.15 | 0.12 |
| EBIT Margin | -0.52 | 0.26 | - | -0.74 | -0.09 | -0.29 |
| Profit Margin | -0.71 | 0.03 | -0.40 | -0.86 | -0.12 | -0.36 |
| EBITDA | -1.17 Billion | 566.65 Million | - | -5.45 Billion | -726.72 Million | -2.32 Billion |
| Earnings Before Tax Margin | -2.03 | -1.88 | -0.46 | -0.44 | -0.39 | -0.41 |
6835
AQN
CABA
SHOP
7868
ELLO